Development and pilot testing of AYA-RISE, a risk information and screening education intervention for adolescents and young adults with cancer risk syndromes

Read full text
Authors: Junne Kamihara, Lauren Fisher, Jaclyn Schienda, Rebecca A. Vanderwall, Moran Snir, Guy Snir, Emilie Simmons, Andrew Khalaj, Evan Goler, Kayla V. Hamilton, Christopher C. Porter, Bojana Pencheva
+11 more Joshua David Schiffman, Luke Devon Maese, Wendy Kohlmann, Tara Olive Henderson, J. Garber, Lisa R. Diller, Ami Vijay Desai, Sarah Case Savage, James Ledlie Klosky, Huma Q. Rana, Jennifer W. Mack
Cited by: 1
References: 33

Abstract

Genetic testing is increasingly recommended for adolescents and young adults (AYAs) with cancer; however, no AYA-specific models for cancer risk communication have been developed. We developed a chatbot-based patient- and family-centered cancer risk communication tool, the AYA-RISE (AYA-Risk Information and Screening Education) intervention for AYAs aged 12–24 years.The intervention was developed together with AYAs with cancer risk syndromes, their family members, and clinicians, using Invitae’s Gia® chatbot (study Phase 1). 17 AYAs participated in a group discussion and completed surveys for input regarding development. Content was developed for 9 different syndromes. AYA-RISE was then refined after iterative input (Phase 2) and evaluated for feasibility and preliminary outcomes in a pilot study (Phase 3).100% of AYAs used the intervention through a point at which risk information was presented via the chatbot and portal demonstrating enrollment and chatbot use feasibility. Our threshold for acceptability was exceeded, with a post-test Acceptability of Intervention Measure (AIM) score of > 4 by 80% of AYAs. In the pre-visit survey, 40% of AYAs correctly reported risk of cancer by age 30, and 20% correctly reported lifetime cancer risk. Following the visit and use of the chat, 60% correctly reported risk of cancer by age 30 and 90% correctly reported lifetime risk. No significant differences in participant pre (3.4) and post (3.6, p=.34) distress thermometer mean scores were observed.The AYA-RISE intervention was feasible and acceptable for use by AYAs. Preliminary outcomes included improved knowledge when used in conjunction with a cancer risk clinic visit, without increasing distress. A randomized trial is currently ongoing.

Fields of Study & Subjects

Childhood Cancer Survivors' Quality of Life BRCA gene mutations in cancer Genomics and Rare Diseases

Publication details

Journal / source
Familial Cancer
Publisher
Springer Science and Business Media LLC
Volume
25
Issue
1
Pages
11–11
Publication date
23 January 2026
Language
EN